OpenAI is set to launch GPT-5.6 after a US security review, raising new questions for enterprise AI access, safeguards, and governance.
Insilico Medicine (Insilico or the Company, HKEX: 3696), a generative artificial intelligence (AI)-driven clinical-stage ...
After two years of maxxing out on AI tools, many organizations are confronting an uncomfortable reality: AI costs don't scale linearly with adoption.
A fraction of promised climate money reaches Amazon communities: Interview with Latimpacto’s leaders
The Amazon is the largest rainforest on Earth, with many funders making financial commitments to conserve this crucial ...
VNET Group rides the AI infrastructure wave but faces extreme equity sensitivity due to high leverage and thin residual value ...
Explore how entrepreneurs and SMEs fuel innovation, job creation, and long-term economic prosperity beyond traditional ...
China is accelerating the integration of artificial intelligence into mineral resource exploration, with experts at a recent ...
Despite near-term headwinds, RxSight has long-term upside from the Alcon royalty partnership, stronger margins and discounted ...
Indian equity benchmarks opened lower amid fresh tensions between the US and Iran. At the open, Sensex fell over 400 points ...
Championed by managed GPU Clusters and centralized data centers, cloud AI relies on infrastructure that expands the ...
Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...
New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing the industry's first quantitative business case for risk-based oversight in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results